HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 292.68 billion as of April 10, 2026. Its market cap has decreased by -58.14% in one year.

Market Cap

292.68B

Enterprise Value

310.84B

Revenue

69.56B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,320.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 292.68B, an increase of 176.62%. That is a compound annual growth rate of 6.54%.

Market Cap History

Date	Market Cap	% Change
Apr 10, 2026	292.68B	16.20%
Dec 30, 2025	251.87B	-73.05%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Genomictree	412.29B
Anterogen.Co.,Ltd.	399.74B
Helixmith	354.10B
BINEX	344.59B
GC Cell	340.36B
JETEMA,	267.91B
Bioneer	256.81B
EASY BIO,Inc.	245.14B

Market Cap Rankings